CEPI visited GHIT to discuss
strengthening partnership in the development of tools to fight infectious diseases.
On October 18, 2022, the Coalition for Epidemic Preparedness Innovations (CEPI) visited the Global Health Innovative Technology Fund (GHIT) to discuss strengthening partnerships in the development of tools to fight infectious diseases.
From left to right: Dr.Hayato Urabe, Senior Director, Investment Strategy, Portfolio Development & Innovations, GHIT,
Kio Yamabe, Chief Operating Officer, GHIT,
Dr. Richard Hatchett, CEO of CEPI,
Dr. Melanie Saville, Executive Director, Research and Development
CEPI and GHIT have aligned mandates, with both agencies funding equitable-access focused research and development for medical countermeasures. The two organizations signed a Memorandum of Understanding (MoU) in May 2022 to strengthen collaboration between them as they work to advance the development of tools to fight infectious diseases.
Dr. Richard Hatchett, CEO of CEPI, and other members of CEPI’s R&D leadership team visited GHIT to discuss strategic vaccine development and investment platforms for the future.
Dr. Osamu Kunii CEO and Executive Director of GHIT, said:
"CEPI's visit has further deepened our strategic discussions for the future. Through the partnership with CEPI, we at GHIT continue our commitment to accelerating R&D for neglected infectious diseases.”
Dr. Richard Hatchett, CEO of CEPI, said:
“The GHIT and CEPI teams had a very productive meeting today and identified several areas of potential collaboration and coordination of effort, including work to advance the 100 Days Mission, work with mutual partners including SCARDA, and potential staff exchanges. We very much look forward to deepening our partnership.”